Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Numinus Wellness Inc (NUMI.TO)

Numinus Wellness Inc (NUMI.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Numinus Wellness Inc 801 - 33 Water Street Vancouver BC V6B 1R4 CAN

https://www.numinus.ca P: 883-686-4687

Description:

Numinus Wellness Inc develops proprietary, psychedelic-centered, therapeutic products and services through its laboratory and research & development processes. The company's clinic network consists of Numinus Health, Mindspace Services, and the Neurology Center of Toronto. Its services include Ketamine-assisted psychotherapy for depression, neurological care, psychotherapy, and counseling by registered psychologists among others. The company's operating segments are; Clinical research operations, Canadian clinic network, US clinic network and Corporate. The majority of the revenue for the company is generated from US clinic network segment. Geographically, the company has its presence in United States and Canada.

Key Statistics

Overview:

Market Capitalization, $K 30,452
Shares Outstanding, K 320,552
Annual Sales, $ 23,180 K
Annual Net Income, $ -30,256 K
Last Quarter Sales, $ 5,946 K
Last Quarter Net Income, $ -4,406 K
60-Month Beta 1.59
% of Institutional Shareholders 2.50%

Growth:

1-Year Return -43.24%
3-Year Return -90.09%
5-Year Return 0.00%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm -0.11
EPS Growth vs. Prev Year -45.00%
Dividend Payout Ratio 0.00%

NUMI.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -122.39%
Return-on-Assets % -85.38%
Profit Margin % -130.53%
Debt/Equity 0.40
Price/Sales 1.07
Price/Book 3.01
Book Value/Share 0.03
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar